Boehringer Ingelheim Venture Fund

Venture Capital

Germany+ United States

Boehringer Ingelheim Venture Fund is a Seed/Series A/Series B investor in Germany. Focus: Healthcare, MedTech, Biotech, Life Sciences. Cheques up to €350M.

boehringer-ingelheim-venture.com Portfolio contact@boehringer-ingelheim-venture.com

Min Ticket

—

Max Ticket

€350M

Stages

3 stages

Sectors

4 sectors

Investment Rounds

Seed Series A Series B

Investment Sectors

Healthcare MedTech Biotech Life Sciences

Details

Headquarters: Berlin, Germany
Other Locations: United States
Min Ticket: Not disclosed
Max Ticket: €350M
Reported Size: €350M
General Email: contact@boehringer-ingelheim-venture.com

View Portfolio

See companies Boehringer Ingelheim Venture Fund has invested in

Similar investorsBy overlapping sectors and HQ country

Think.Health

Berlin, Germany

415 Capital

Munich, Germany

Luminous Ventures

London, United Kingdom

UCB Ventures

Brussels, Belgium

Biomark Capital

Greenwich, United States

Hadean Ventures

Oslo, Norway